Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 112
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Mastijet Forte - V/NRP/96/0344 Intervet International B.V., Nīderlande QJ51RV01 lactating cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Bacitracin,Neomycin,Prednisolone,Tetracycline hydrochloridum
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 21-Mar-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-May-2018)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-May-2018)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-May-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0344-01 20 Injektors, 1 deva [PDF] [PDF]
T61 - V/NRP/02/1429 Intervet International B.V., Nīderlande QN51AX50 guinea pigs; hamsters; cattle; pigs; horses; mouses; rats; dogs; cats; rabbits; minks; pigeons Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Embutramide, Mebezonium iodide, Tetracaine hydrohchloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International GmbH, Vācija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1429-01 1 Stikla pudele (dzintarkrāsas), 50 ml -
Hefrotrim - V/NRP/95/0251 Alivira Animal Health Limited,, Īrija QJ01EW03 cattle; pigs; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Trimethoprim, Sulfadimidine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Karizoo S.A., Spānija
Date of authorisation/renewal: 04-Apr-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/95/0251-01 1 Stikla pudelīte, 50 ml -
V/NRP/95/0251-02 1 Stikla flakons, 100 ml -
V/NRP/95/0251-03 10 Stikla pudelīte, 50 ml -
V/NRP/95/0251-04 12 Stikla flakons, 100 ml -
Ingelvac MycoFLEX - V/MRP/09/0014 Boehringer Ingelheim Vetmedica GmbH, Vācija QI09AB13 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Mycoplasma hyopneumoniae
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 08-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/09/0014-08 12 ABPE pudele, 250 ml -
V/MRP/09/0014-09 1 ABPE pudele, 50 ml -
V/MRP/09/0014-10 1 ABPE pudele, 10 ml -
V/MRP/09/0014-11 12 ABPE pudele, 10 ml -
V/MRP/09/0014-12 12 ABPE pudele, 50 ml -
V/MRP/09/0014-13 1 ABPE pudele, 250 ml -
V/MRP/09/0014-14 1 ABPE pudele, 100 ml -
V/MRP/09/0014-15 12 ABPE pudele, 100 ml -
V/MRP/09/0014-16 12 ABPE TwistPak pudele, 250 ml -
V/MRP/09/0014-17 1 ABPE TwistPak pudele, 50 ml -
V/MRP/09/0014-18 1 ABPE TwistPak pudele, 10 ml -
V/MRP/09/0014-19 12 ABPE TwistPak pudele, 10 ml -
V/MRP/09/0014-20 12 ABPE TwistPak pudele, 50 ml -
V/MRP/09/0014-21 1 ABPE TwistPak pudele, 250 ml -
V/MRP/09/0014-22 1 ABPE TwistPak pudele, 100 ml -
V/MRP/09/0014-23 12 ABPE TwistPak pudele, 100 ml -
Avishield ND B1 - V/DCP/18/0017 Izo S.r.l., Itālija QI01AD06 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oculonasal suspension/use in drinking water
International name (active substance): Live Newcastle dis.virus str.Hitchner B1
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Genera d.d., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (05-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0017-01 10 Stikla flakons, 1000 deva -
V/DCP/18/0017-02 10 Stikla flakons, 2500 deva -
V/DCP/18/0017-03 10 Stikla flakons, 5000 deva -
Avishield IB QX - V/DCP/25/0049 Izo S.r.l., Itālija QI01AD07 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oculonasal suspension/use in drinking water
International name (active substance): Avian infectious bronchitis virus, type QX, strain 1285, Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Genera d.d., Horvātija
Date of authorisation/renewal: 10-Jul-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (05-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0049-01 10 Stikla flakons, 1000 deva -
V/DCP/25/0049-02 10 Stikla flakons, 2500 deva -
V/DCP/25/0049-03 10 Stikla flakons, 5000 deva -
Bimacure 500 mg V/DCP/22/0029 Bimeda Animal Health Limited, Īrija QG51AA05 cattle Vairāk

Medicinal product information

Pharmaceutical form: intrauterine suspension
International name (active substance): Cephapirin benzathine
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma France, Francija
Date of authorisation/renewal: 27-Jul-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0029-01 10 polietilēna šļirce, 19 g -
BIOSUIS Entero - V/DCP/24/0028 Bioveta a.s., Čehija QI09AL09 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Porcine rotavirus, serogroup A, strain OSU 6, Inactivated, Escherichia coli, serotype O149:K88 (fimbrial adhesin F4ac), Inactivated, Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated, Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated, Clostridium perfringens, type C, beta toxoid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta a.s., Čehija
Date of authorisation/renewal: 10-Apr-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0028-01 1 Stikla flakons, 10 ml -
V/DCP/24/0028-02 1 Stikla flakons, 50 ml -
V/DCP/24/0028-03 1 Stikla flakons, 100 ml -
V/DCP/24/0028-04 1 ABPE flakons, 50 ml -
V/DCP/24/0028-05 1 ABPE flakons, 100 ml -
V/DCP/24/0028-06 1 ABPE flakons, 250 ml -
V/DCP/24/0028-07 10 Stikla flakons, 10 ml -
Karbetocin Bioveta 0.07 mg/ml V/DCP/25/0072 Bioveta a.s., Čehija QH01BB03 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Carbetocin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 05-Dec-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (05-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0072-01 1 Stikla flakons, 10 ml -
V/DCP/25/0072-02 1 Stikla flakons, 50 ml -
Kelevo 800 µg/tabl. V/DCP/21/0032 Industrial Veterinaria, S.A., Spānija QH03AA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0032-01 5 Alumīnija blisteris, 10 tablete -
V/DCP/21/0032-02 10 Alumīnija blisteris, 10 tablete -
V/DCP/21/0032-03 10 Alumīnija blisteris, 25 tablete -
V/DCP/21/0032-04 25 Alumīnija blisteris, 10 tablete -
V/DCP/21/0032-05 2 Alumīnija blisteris, 25 tablete -
V/DCP/21/0032-06 4 Alumīnija blisteris, 25 tablete -
Kelevo 400 µg/tabl. V/DCP/21/0033 Industrial Veterinaria, S.A., Spānija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0033-01 5 Alumīnija blisteris, 10 tablete -
V/DCP/21/0033-02 10 Alumīnija blisteris, 25 tablete -
V/DCP/21/0033-03 10 Alumīnija blisteris, 10 tablete -
V/DCP/21/0033-04 25 Alumīnija blisteris, 10 tablete -
V/DCP/21/0033-05 2 Alumīnija blisteris, 25 tablete -
V/DCP/21/0033-06 4 Alumīnija blisteris, 25 tablete -
Kelevo 200 µg/tabl. V/DCP/21/0034 Industrial Veterinaria, S.A., Spānija QH03AA01 dogs; cats

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0034-01 5 Alumīnija blisteris, 10 tablete -
V/DCP/21/0034-02 10 Alumīnija blisteris, 25 tablete -
V/DCP/21/0034-03 10 Alumīnija blisteris, 10 tablete -
V/DCP/21/0034-04 25 Alumīnija blisteris, 10 tablete -
V/DCP/21/0034-05 2 Alumīnija blisteris, 25 tablete -
V/DCP/21/0034-06 4 Alumīnija blisteris, 25 tablete -
Ketosol-100 100 mg/ml V/MRP/18/0035 Interchemie Werken De Adelaar Eesti AS, Igaunija QM01AE03 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ketoprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 30-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0035-01 1 Stikla flakons, 100 ml -
V/MRP/18/0035-02 1 Stikla flakons, 50 ml -
Ketabel 100 mg/ml V/DCP/20/0038 Bela-pharm GmbH&Co.KG, Vācija QN01AX03 guinea pigs; hamsters; cattle; pigs; sheep; goats; horses; mouses; rats; dogs; cats; rabbits Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ketamine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0038-01 1 Stikla flakons, 10 ml -
V/DCP/20/0038-02 10 Stikla flakons, 10 ml -
V/DCP/20/0038-03 1 Stikla flakons, 25 ml -
V/DCP/20/0038-04 10 Stikla flakons, 25 ml -
Biomectin 1% 10 mg/ml V/NRP/96/0466 Vetoquinol Biowet Sp. z o.o., Polija QP54AA01 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol Biowet Sp. z o.o., Polija
Date of authorisation/renewal: 26-Feb-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0466-01 10 mg/ml 1 Stikla flakons, 20 ml -
V/NRP/96/0466-02 10 mg/ml 1 Stikla flakons, 50 ml -
V/NRP/96/0466-03 10 mg/ml 1 Stikla flakons, 100 ml -
V/NRP/96/0466-04 10 mg/ml 1 Stikla flakons, 250 ml -
V/NRP/96/0466-05 10 mg/ml 1 Plastmasas flakons, 500 ml -
Zoletil 100 - V/NRP/07/1711 Virbac S.A., Francija QN01AX99 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for solution for injection
International name (active substance): Zolazepam hydrochloride, Tiletamine hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 15-Jan-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 11112025LI (11-Nov-2025)
Labelling text: [DOCX] 11112025M (11-Nov-2025)
Summary of product characteristics: [DOCX] 11112025ZA (11-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1711-01 1 Flakons (šķīdinātājs), 5 ml;Flakons (liofilizāts), 970 mg -
Fypryst 402 mg - V/DCP/10/0010 KRKA, d.d., Novo mesto, Slovēnija QP53AX15 dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/10/0010-01 402 mg 3 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0010-02 402 mg 1 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0010-03 402 mg 6 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0010-04 402 mg 10 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0010-05 402 mg 20 Plastikāta tūbiņa, 1 deva -
Trymox LA 150 mg/ml V/DCP/19/0019 Univet Ltd., Īrija QJ01CA04 cattle; pigs; sheep; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Amoxicillin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Univet Ltd., Īrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0019-01 150 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/19/0019-02 150 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/19/0019-03 150 mg/ml 1 Stikla flakons, 250 ml -
V/DCP/19/0019-04 150 mg/ml 1 PET pudele, 100 ml -
V/DCP/19/0019-05 150 mg/ml 1 PET pudele, 250 ml -
V/DCP/19/0019-06 150 mg/ml 12 Stikla flakons, 50 ml -
V/DCP/19/0019-07 150 mg/ml 12 Stikla flakons, 100 ml -
V/DCP/19/0019-08 150 mg/ml 12 PET pudele, 100 ml -
V/DCP/19/0019-09 150 mg/ml 6 Stikla flakons, 250 ml -
V/DCP/19/0019-10 150 mg/ml 6 PET pudele, 250 ml -
Telmitraxx 4 mg/ml V/DCP/23/0024 Alfasan Nederland BV, Nīderlande QC09CA07 cats Vairāk

Medicinal product information

Pharmaceutical form: Oral solution
International name (active substance): Telmisartan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-Jun-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Jul-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0024-01 1 ABPE pudele, 30 ml -
V/DCP/23/0024-02 1 ABPE pudele, 60 ml -
V/DCP/23/0024-03 1 ABPE pudele, 90 ml -
V/DCP/23/0024-04 1 ABPE pudele, 200 ml -
Vetmedin S 2.5 mg V/MRP/15/0012 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lavet Pharmaceuticals, Ungārija
Date of authorisation/renewal: 02-Jan-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0012-01 2,5 mg 2 PVH/Al blisteris, 10 tablete -
V/MRP/15/0012-02 2,5 mg 5 PVH/Al blisteris, 10 tablete -
V/MRP/15/0012-03 2,5 mg 10 PVH/Al blisteris, 10 tablete -

3082 records